AGL agilon health, inc.
$90.65▲ +0.34%
Healthcare
Other
Volume 123.8K
Avg Volume (10D) 170.1K
Key Metrics & Fundamentals
Market Cap
$1.52B
P/E Ratio
–
Div Yield
0.00%
52W Range
7.48 - 133.04
% vs 50 MA
2.70%
% vs 200 MA
41.55%
RSI-14
56.3
MACD Histogram
+0.7900
Beta (1Y vs SPY)
2.47
Free Cash Flow
-$61.60M
Gross Rev
$1.49B
Gross Profit
$107.14M
EBITDA
$26.05M
COGS
$1.39B
Operating Exp
$95.37M
Operating Income
$11.77M
EBIT
$11.77M
Pretax Income
$17.58M
Net Income
$17.96M
EPS (Diluted)
1.04
Price & Volume History
Loading chart…
Recent News
Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Zacks · Oct 23, 2026 8:40 AM ET
agilon health (AGL): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · Oct 21, 2026 1:10 PM ET
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
StockStory · Oct 19, 2026 6:00 PM ET
2 High-Flying Stocks with Competitive Advantages and 1 We Question
StockStory · Oct 16, 2026 10:19 AM ET
Why Did agilon health (AGL) Move Today?
Simply Wall St. · Oct 8, 2026 9:18 AM ET
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Zacks · Oct 7, 2026 8:40 AM ET
agilon health Sets Date to Report Third Quarter 2026 Financial Results
Business Wire · Oct 5, 2026 4:05 PM ET
1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds
StockStory · Oct 1, 2026 3:41 AM ET
Agilon Health Adds Jackson Clinic to Senior Health Connect ACO
MT Newswires · Sep 30, 2026 1:22 PM ET
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Business Wire · Sep 30, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AGL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.